The Minnesota Psychedelic Medicine Task Force (PMTF) has taken significant strides toward recommending a framework for regulating psychedelic substances, including psilocybin, MDMA, and LSD. The group has approved a state-regulated psilocybin therapy program and allocated research funding, but the decriminalization of personal possession remains unresolved. The task force’s work reflects a growing societal debate about psychedelic use and its potential therapeutic applications.
The new single ‘Microdose’ by Johnny Slash, DJ Hoppa, and Wrekonize, released under the Broken Complex label, blends psychedelic beats, sharp lyricism, and experimental production to create a unique and immersive auditory experience. The track explores themes of self-awareness, reflection, and the transcendental, reflecting a growing trend of artists incorporating altered states of consciousness into their music.
Irish psychedelic biotech firm GH Research PLC (GHRS) reported its second-quarter financial results, highlighting a net loss of $10.4 million but significant progress in clinical trials for its DMT-related drug candidates. The company is investigating two mebufotenin-based products for treatment-resistant depression.
Psyence Biomedical’s stock (PBM) plummeted 28.6% on Wednesday after the company announced an exclusive licensing agreement with PsyLabs for pharmaceutical-grade psilocybin. The agreement aims to facilitate clinical trials and potential commercialization of psychedelic treatments for conditions like alcohol use disorder and Adjustment Disorder in cancer patients.
